Laminin-1 and the RKRLQVQLSIRT laminin-1 alpha1 globular domain peptide stimulate matrix metalloproteinase secretion by PC12 cells.

Department of Biology, Adelphi University, Garden City, New York 11530, USA.
Experimental Cell Research (Impact Factor: 3.37). 10/1998; 243(2):375-82. DOI: 10.1006/excr.1998.4157
Source: PubMed

ABSTRACT Here we have investigated the ability of laminin-1 and specific laminin-1-derived synthetic peptides to stimulate neuronal cell matrix metalloproteinase secretion. Zymographic analysis of conditioned media from laminin-1-treated PC12 and NG108-15 cells revealed a 72-kDa matrix metalloproteinase which was not secreted by untreated cells. Laminin-1 alpha1 chain-derived synthetic peptides, AASIKVAVSADR (LAM-L) and RKRLQVQLSIRT (AG-73), also stimulated PC12 cell secretion of a 72-kDa matrix metalloproteinase. We further investigated the structural requirements of AG-73 for cell attachment, neurite outgrowth, and matrix metalloproteinase secretion using a series of AG-73 analogs that had single amino acids substituted with alanine. At the substrate levels tested, the AG-73 peptide promoted the adhesion of 67% of the PC12 cells and neurite outgrowth in 71% of the PC12 cells. Substitutions in any one of the amino acids within the central LQVQ sequence resulted in a large reduction in cell attachment whereas substitution in the carboxyl terminal proximal amino acids L, S, and R had little effect on attachment. Alanine substitution of any of the amino terminal proximal LQV amino acids and the carboxyl terminal L, I, and R residues resulted in a 65-91% reduction in neurite outgrowth. These data demonstrate that the sequence requirements for cell attachment and neurite outgrowth were not necessarily coupled but that the sequence requirements for neurite outgrowth and matrix metalloproteinase secretion were identical. We conclude that laminin-1 is able to stimulate neuronal cells to secrete a matrix metalloproteinase. Further, this study identifies the LQVXLXIR laminin-1 alpha1 globular domain peptide to be capable of stimulating both neurite outgrowth and matrix metalloproteinase secretion.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Poly(L-lactic acid) (PLLA) is widely used as a scaffold but does not possess biological functions. Here, we described the biosynthesis of the elastin-like repetitive polypeptide (VPGIG)30 containing a laminin-derived neurite outgrowth-promoting sequence (RKRLQVQLSIRT: AG73) (AG73-(VPGIG)30). The expression vector for AG73-(VPGIG)30 was constructed using the self-ligation technique to elongate the VPGIG repetitive sequence. The coacervation temperature of the purified AG73-(VPGIG)30 protein was 20 and 14 °C in water and phosphate-buffered saline (PBS), respectively. AG73-(VPGIG)30 was quickly adsorbed on PLLA films via a hydrophobic interaction by raising the temperature from 4 °C to 37 °C. On the AG73-(VPGIG)30-modified PLLA surface, the neurite outgrowth of PC12 cells was strongly promoted. We successfully induced the neurite outgrowth activity on PLLA films by treating the novel surface modifier AG73-(VPGIG)30, which could be applicable in developing PLLA scaffolds for nerve regeneration.
    07/2014; 2(31). DOI:10.1039/C4TB00305E
  • [Show abstract] [Hide abstract]
    ABSTRACT: In this study, an artificial multi-functional extracellular matrix (ECM) protein, tethered with a growth factor, was developed for neurite outgrowth induction. The designed ECM protein was comprised of an elastin-like peptide, as a structural unit, as well as the AG73 peptide sequence derived from the laminin and the C3 peptide sequence, which binds to neural cell adhesion molecules (derived from a synthetic peptide library) as functional units. Both AG73 and C3 have been demonstrated to promote cell adhesion and enhance neurite outgrowth. For the tethering of basic fibroblast growth factor (bFGF) to the ECM protein, helical peptides were fused to the ECM protein to form a coiled-coil helical structure with helical peptide-fused bFGF. Neurite outgrowth was induced in the PC12 cells that were cultured on this ECM protein as a result of the tethered-bFGF. Moreover, neurite outgrowth was enhanced by the AG73 and C3 peptides of the ECM protein.
    Biomedical Materials 12/2013; 9(1):015004. DOI:10.1088/1748-6041/9/1/015004 · 2.92 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Laminins are a multifunctional molecule with numerous active sites that have been identified in short peptide sequences. Mixed peptide-conjugated chitosan membranes using laminin-derived active peptides have been previously demonstrated to be useful as a biomaterial for tissue engineering. In this study, two syndecan-binding peptides, AG73 (RKRLQVQLSIRT) and C16 (KAFDITYVRLKF), and three integrin-binding peptides, EF1zz (ATLQLQEGRLHFXFDLGKGR, X: Nle, binding to integrin α2β1), A99a (ALRGDN, binding to integrin αvβ3), and A2G10 (SYWYRIEASRTG, binding to integrin α6β1), were mixed in various combinations, conjugated to chitosan membranes, and evaluated for their cell attachment and spreading activities. The cell attachment and spreading activity of EF1zz, A99a, and A2G10 were enhanced by AG73. In contrast, C16 enhanced only the cell attachment and spreading activity of A99a and did not influence the activity of EF1zz and A2G10. As well as previous study, the AG73-chitosan membrane bound to only syndecan. On the other hand, the C16-chitosan membrane interacted with both syndecan and β1 integrin. These data suggest that interaction of different receptors can cause synergistic effects. Therefore, AG73 is widely applicable as a synergistic agent for mixed peptide-matrices using several types of integrin-binding peptides. Additionally, the A2G10/AG73-chitosan membrane may be useful to investigate detailed biological functions of α6β1 integrin, which is a major laminin-binding receptor. Using a combination of tissue-appropriate laminin-derived peptides, the mixed peptide-chitosan membranes may serve as functional biomaterials for tissue engineering. © 2013 Wiley Periodicals, Inc. Biopolymers, 2013.
    Biopolymers 11/2013; 100(6). DOI:10.1002/bip.22303 · 2.29 Impact Factor